To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC23733 | MRS 2481 |
MRS 2481 is a potent, reversible Aβ42 neurotoxicity inhibitor with ID50 of 500 nM, potently blocks the Aβ calcium channel and protects neurons from Aβ toxicity.
More description
|
|
| DC23471 | MRS 2179 tetrasodium |
MRS 2179 is a potent, selective, competitive P2Y1 receptor antagonist with Kb of 100 nM.
More description
|
|
| DC23483 | MRS 2179 |
MRS 2179 is a potent, selective, competitive P2Y1 receptor antagonist with Kb of 100 nM.
More description
|
|
| DC23711 | MRL20 |
MRL20 is a novel synthetic PPARγ ligand and orthosteric agonist with canonical LBP binding affinity of 2 nM.
More description
|
|
| DC21343 | MRL-1237 |
MRL-1237 is a potent and selective inhibitor of the replication of Enteroviruses with EC50 of 1-10 uM, targets the nonstructural 2C protein.
More description
|
|
| DC21923 | MRK-A |
MRK-A is a potent, highly selective, brain penetrant inhibitor of mutant IDH1 with IC50 of 5 nM, displays a 10,000-fold mutant to wildtype selectivity ratio.
More description
|
|
| DC23616 | MRK-696 |
MRK-696 is a non-selective benzodiazepine receptor partial agonist..
More description
|
|
| DC23655 | MRK-623 |
MRK-623 is a potent, α2/α3 subunit functionally selectiviie GABAA receptor agonist..
More description
|
|
| DC23877 | MRK-560 |
MRK-560 is a potent, brain-penetrant and orally bioavailable γ-secretase inhibitor that inhibits proteolytic cleavage of APP over the Notch pathway.
More description
|
|
| DC3122 | MRK003 |
MRK003 is a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma.
More description
|
|
| DC10938 | MPT0G211 |
MPT0G211 is a novel potent, selective HDAC6 inhibitor with IC50 of 0.291 nM, displays >1,000-fold selectivity over other HDAC isoforms.
More description
|
|
| DC10951 | MPT0E028 |
MPT0E028 is a potent HDAC inhibitor that inhibits nuclear HDAC activity with IC50 of 11.1 nM in HeLa cells, 9-30 times more potent than SAHA.
More description
|
|
| DC11241 | MP-HJ-1b |
MP-HJ-1b is a novel potent inhibitor of microtubule and tumor cell growth, binds the colchicine pocket at the intra-dimer interface, depolymerizes microtubules and affects spindle formation.
More description
|
|
| DC20465 | mPGES1-IN-17d |
mPGES1-IN-17d is a potent, selective mPGES-1 inhibitor with enzyme IC50 of 8 nM, A549 cell IC50 of 16.24 nM, human whole blood IC50 of 249.9 nM.
More description
|
|
| DC20464 | mPGES1-IN-16 |
mPGES1-IN-16 is a potent and selective mPGES-1 inhibitor with IC50 of 1 nM.
More description
|
|
| DC7202 | MPC-3100 |
MPC-3100 is an orally bioavailable, synthetic, second-generation small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
More description
|
|
| DC11856 | MPC-0767 |
MPC-0767 (MPC0767, MPC3100 mesylate hydrate) is an L-alanine ester prodrug of MPC-3100, which is a potent, selective, orally bioavailable Hsp90 inhibitor with IC50 of 0.14 uM.
More description
|
|
| DC22554 | MP-A08 |
MP-A08 is a first-in-class, highly selective, ATP competitive sphingosine kinase (SphK) inhibitor (Ki of 6.9/27 uM for SK2/SK1).
More description
|
|
| DC10326 | Mozavaptan |
Mozavaptan (OPC31260) is a orally effective, nonpeptide vasopressin V2 receptor antagonist with an IC50 of 14 nM.
More description
|
|
| DC12485 | Mosedipimod |
Mosedipimod (EC-18, 1-palmitoyl-2-linoleoyl-3-acetylglycerol) is a synthetic monoacetyldiaglyceride that stimulates T cell production of IL-2, IL-4, IL-12, IFN-γ, and GM-CSF in vitro.
More description
|
|
| DC8931 | Mosapride |
Mosapride is a gastroprokinetic agent that acts as a selective 5HT4 agonist.
More description
|
|
| DC20042 | Monooctyl succinate |
Monooctyl succinate is a monoester, which can be used as a surfactants and a potential fragrance releaser.
More description
|
|
| DC9425 | Molindone (hydrochloride) |
Molindone is a therapeutic antipsychotic, used in the treatment of schizophrenia, works by blocking the effects of dopamine in the brain, leading to diminished psychoses.
More description
|
|
| DC9326 | Moexipril (hydrochloride) |
Moexipril HCl is a potent orally active non-sulfhydryl angiotensin converting enzyme(ACE) inhibitor, which is used for the treatment of hypertension and congestive heart failure.
More description
|
|
| DC20462 | MNK-IN-54 |
MNK-IN-54 is a potent, orally bioavailable dual MNK1/2 and BCR-ABL1 inhibitor with IC50 of 20/10/200/10 nM for Abl T315I/ wt Abl/MNK1/MNK2, respectively.
More description
|
|
| DC21336 | MNKI-8e |
MNKI-8e (MNK inhibitor 8e) is a potent, selective MNK inhibitor that inhibits Mnk2 with Ki of 0.37 uM, displays >34-fold and 4-fold over CDK2 (Ki>10 uM) and CDK9 (Ki=1.66 uM).
More description
|
|
| DC21338 | MNKI-85 |
MNKI-85 is a potent and selective Mnk2 inhibitor with Ki of 31 nM, displays no inhibitory activities against Mnk1, CDK2A, CDK9T, and CDK4D.
More description
|
|
| DC21337 | MNKI-19 |
MNKI-19 is a potent and dual-specific Mnk inhibitor with Ki of 186 nM and 68 nM for Mnk1 and Mnk2, respectively.
More description
|
|
| DC20463 | MNK inhibitor 9 |
MNK inhibitor 9 is a potent, selective MAPK-interacting kinase (MNK1 and MNK2) inhibitor with IC50 of 3 nM for both, with no activity aginst CDK1/2 (IC50>25 uM).
More description
|
|
| DC21275 | MN30 |
MN30 (Methyl-3,4-dephostatin, APOBEC3G inhibitor MN30) is a first-in-class, selectve small molecule inhibitor of the single-strand DNA cytosine deaminase APOBEC3G with IC50 of 9.1 uM.
More description
|
|